Use of serum blank information to quantify chromogenic interferents and correct sensitive analyses.
Burtner
K
K
Advanced Development, Research and Development, Baxter Healthcare Corp., Irvine, CA 92718.
Huber
M
M
Frye
S
S
D001663:Bilirubin / Q000032:analysis / Q000592:standards; D002863:Chromogenic Compounds / Q000592:standards*; D006454:Hemoglobins / Q000032:analysis / Q000592:standards; D006801:Humans; D008055:Lipids / Q000032:analysis / Q000592:standards; D015203:Reproducibility of Results; D013053:Spectrophotometry / Q000379:methods / Q000592:standards*
D002863:Chromogenic Compounds; D006454:Hemoglobins; D008055:Lipids; D001663:Bilirubin